Representing over 60% of our recent experience, Oncology studies are one of the areas in which Ergomed excels. By using our unique site management and study physician models, we are able to identify and enroll patients across the globe, while ensuring compliance to local regulatory requirements. Furthermore, our full-service offering allows us to provide a complete solution for your program’s unique requirements.
Rare Disease trials have specific requirements and are not just smaller versions of significant trials. We focus on the rare disease patient, and how to make a positive impact on their lives with our family-centric approach. Ergomed has a strong heritage in assisting biotech and pharma companies with orphan drug development offering a full range of high-quality clinical research and trial management services and we are proud to share our expertise.
With a rapidly changing landscape, neurological disorder trials are transforming and adapting. Ergomed can assist you to develop your protocol, determine inclusion / exclusion criteria, and create a feasibility plan to maximise study effectiveness. Our global access to key opinion leaders, leading investigative sites and site management model ensure that we can guide you through this rapidly growing field.